Literature DB >> 18992011

Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering.

Hiroyuki Itosaka1, Satoshi Kuroda, Hideo Shichinohe, Hiroshi Yasuda, Shunsuke Yano, Shintaro Kamei, Ryoichi Kawamura, Kazutoshi Hida, Yoshinobu Iwasaki.   

Abstract

Recent basic experiments have strongly suggested that cell transplantation therapy may promote functional recovery in patients with spinal cord injury (SCI). However, a safe and efficient transplantation technique still remains undetermined. This study, therefore, was aimed to clarify whether fibrin matrix could be a useful scaffold in bone marrow stromal cell (BMSC) transplantation for the injured spinal cord. To clarify the issue, three-dimensional structure of fibrin matrix was assessed and the green fluorescent protein (GFP)-expressing BMSC were cultured in fibrin matrix. The rats were subjected to spinal cord hemisection at T8 level, and the vehicle, BMSC or BMSC-fibrin matrix construct was implanted into the cavity. Neurologic function was serially evaluated. Using immunohistochemistry, we evaluated the survival, migration and differentiation of the transplanted cells at 4 weeks after transplantation. In the initial in vitro study, the BMSC could survive in fibrin matrix for 2 weeks. The animals treated with the BMSC-fibrin matrix construct showed significantly more pronounced recovery of neurologic function than vehicle- or BMSC-treated animals. Fibrin scaffold markedly improved the survival and migration of the transplanted cells. There was no significant difference in the percentage of cells doubly positive for GFP and microtubule-associated protein 2 between the animals treated with BMSC-fibrin matrix construct and those treated with BMSC, but a certain subpopulation of GFP-positive cells morphologically simulated the neurons in the animals treated with BMSC-fibrin matrix construct. These findings strongly suggest that fibrin matrix may be one of the promising candidates for a potential, minimally invasive scaffold for injured spinal cord, and that such strategy of tissue engineering could be a hopeful option in regeneration therapy for patients with SCI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992011     DOI: 10.1111/j.1440-1789.2008.00971.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  30 in total

1.  Fibrin degradation enhances vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro.

Authors:  Katherine A Ahmann; Justin S Weinbaum; Sandra L Johnson; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 2.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

3.  Host reaction to poly(2-hydroxyethyl methacrylate) scaffolds in a small spinal cord injury model.

Authors:  Hong Ying Li; Tobias Führmann; Yue Zhou; Paul D Dalton
Journal:  J Mater Sci Mater Med       Date:  2013-05-24       Impact factor: 3.896

Review 4.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

Review 5.  Biomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic review.

Authors:  Vibhor Krishna; Sanjay Konakondla; Joyce Nicholas; Abhay Varma; Mark Kindy; Xuejun Wen
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

6.  Upregulation of UBAP2L in Bone Marrow Mesenchymal Stem Cells Promotes Functional Recovery in Rats with Spinal Cord Injury.

Authors:  Guan-Lin Lin; Huan Wang; Jun Dai; Xiao Li; Ming Guan; Qing Ding; Huai-Xi Wang; Huang Fang
Journal:  Curr Med Sci       Date:  2018-12-07

7.  Treatment with basic fibroblast growth factor-incorporated gelatin hydrogel does not exacerbate mechanical allodynia after spinal cord contusion injury in rats.

Authors:  Takeo Furuya; Masayuki Hashimoto; Masao Koda; Atsushi Murata; Akihiko Okawa; Mari Dezawa; Dai Matsuse; Yasuhiko Tabata; Kazuhisa Takahashi; Masashi Yamazaki
Journal:  J Spinal Cord Med       Date:  2013-03       Impact factor: 1.985

Review 8.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

9.  Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Kohsuke Kudo; Masaki Ito; Masahito Kawabori; Michiyuki Miyamoto; Mitsuhiro Nakanishi; Satoshi Terae; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

Review 10.  Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.

Authors:  Christopher S Ahuja; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-04-29       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.